Literature DB >> 23279377

Stretch current-induced abnormal impulses in CaMKIIδ knockout mouse ventricular myocytes.

Dongwu Lai1, Lin Xu, Jun Cheng, Arnaud B Guilbert, Hyun Joung Lim, Guosheng Fu, Yanggan Wang.   

Abstract

BACKGROUND: CaMKII activation is proarrhythmic in heart failure where myocardium is stretched. However, the arrhythmogenic role of CaMKII in stretched ventricle has not been well understood.
OBJECTIVE: We tested abnormal impulse inducibility by stretch current in myocytes isolated from CaMKIIδ knockout (KO) mouse left ventricle (LV) where CaMKII activity is reduced by ≈ 62%. METHODS AND
RESULTS: Action potentials were recorded by whole-cell patch clamp, and abnormal impulses were induced in LV myocytes by a simulation of stretch-activated channel (SAC) current. SAC activation failed to induce abnormal impulses in wild type (WT) myocytes but steadily produced early after-depolarizations and automaticity in KO myocytes in which an increase in L-type calcium channel (LTCC) current (I(Ca)) and a reduction of sarcoplasmic reticulum Ca(2+) leak and action potential duration (APD) were observed. The abnormal impulses were not suppressed by CaMKII inhibitor AIP whereas a low concentration of nifedipine eliminated abnormal impulses without shortening APD, implicating I(Ca) in promoting stretch-induced abnormal impulses. In addition, APD prolongation by LTCC opener S(-)Bay K 8644 or isoproterenol facilitated abnormal impulse induction in WT ventricular myocytes even in the presence of CaMKII inhibitor AIP, whereas APD prolongation by K(+) channel blocker 4-aminopyridine promoted abnormal impulses in KO myocytes but not in WT myocytes.
CONCLUSION: I(Ca) activation plays a central role in stretch-induced abnormal impulses and APD prolongation is arrhythmogenic only when I(Ca) is highly activated. At increased I(Ca) activation, CaMKII inhibition cannot suppress abnormal impulse induction.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23279377      PMCID: PMC3618486          DOI: 10.1111/jce.12060

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  31 in total

Review 1.  Role of stretch-activated channels on the stretch-induced changes of rat atrial myocytes.

Authors:  Jae Boum Youm; Jin Han; Nari Kim; Yin-Hua Zhang; Euiyong Kim; Hyun Joo; Chae Hun Leem; Sung Joon Kim; Kyung A Cha; Yung E Earm
Journal:  Prog Biophys Mol Biol       Date:  2005-07-07       Impact factor: 3.667

Review 2.  Reducing the risk of sudden death in heart failure with beta-blockers.

Authors:  Philip B Adamson; Edward M Gilbert
Journal:  J Card Fail       Date:  2006-12       Impact factor: 5.712

3.  Calmodulin kinase II inhibition protects against structural heart disease.

Authors:  Rong Zhang; Michelle S C Khoo; Yuejin Wu; Yingbo Yang; Chad E Grueter; Gemin Ni; Edward E Price; William Thiel; Silvia Guatimosim; Long-Sheng Song; Ernest C Madu; Anisha N Shah; Tatiana A Vishnivetskaya; James B Atkinson; Vsevolod V Gurevich; Guy Salama; W J Lederer; Roger J Colbran; Mark E Anderson
Journal:  Nat Med       Date:  2005-03-27       Impact factor: 53.440

Review 4.  Mechanisms of sudden cardiac death.

Authors:  Michael Rubart; Douglas P Zipes
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

5.  Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium.

Authors:  B Hoch; R Meyer; R Hetzer; E G Krause; P Karczewski
Journal:  Circ Res       Date:  1999-04-02       Impact factor: 17.367

6.  Stabilisation of medically refractory ventricular arrhythmia by intra-aortic balloon counterpulsation.

Authors:  G D Fotopoulos; M J Mason; S Walker; N S Jepson; D J Patel; A G Mitchell; C D Ilsley; V E Paul
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

7.  Calcium/calmodulin-dependent protein kinase II activity is increased in sarcoplasmic reticulum from coronary artery ligated rabbit hearts.

Authors:  S Currie; G L Smith
Journal:  FEBS Lett       Date:  1999-10-08       Impact factor: 4.124

8.  Modulation of late sodium current by Ca2+, calmodulin, and CaMKII in normal and failing dog cardiomyocytes: similarities and differences.

Authors:  Victor A Maltsev; Vitaliy Reznikov; Nidas A Undrovinas; Hani N Sabbah; Albertas Undrovinas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-18       Impact factor: 4.733

9.  Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure.

Authors:  Yanggan Wang; Samvit Tandan; Jun Cheng; Chunmei Yang; Lan Nguyen; Jessica Sugianto; Janet L Johnstone; Yuyang Sun; Joseph A Hill
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

10.  Remodeling of outward K+ currents in pressure-overload heart failure.

Authors:  Yanggan Wang; Jun Cheng; Guohua Chen; Farhana Rob; R Haris Naseem; Lan Nguyen; Janet L Johnstone; Joseph A Hill
Journal:  J Cardiovasc Electrophysiol       Date:  2007-05-30
View more
  3 in total

1.  The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.

Authors:  Dongwu Lai; Jing Gao; Xukun Bi; Hong He; Xiaolu Shi; Shaoxiang Weng; Yu Chen; Ying Yang; Yang Ye; Guosheng Fu
Journal:  J Mol Med (Berl)       Date:  2016-08-30       Impact factor: 4.599

2.  Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes.

Authors:  Jing Gao; Xiaolu Shi; Hong He; Juhong Zhang; Ding Lin; Guosheng Fu; Dongwu Lai
Journal:  J Vis Exp       Date:  2017-09-18       Impact factor: 1.355

3.  Inhibition of late sodium current suppresses calcium-related ventricular arrhythmias by reducing the phosphorylation of CaMK-II and sodium channel expressions.

Authors:  Xiao-Hong Wei; Shan-Dong Yu; Lu Ren; Si-Hui Huang; Qiao-Mei Yang; Ping Wang; Yan-Peng Chu; Wei Yang; Yan-Sheng Ding; Yong Huo; Lin Wu
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.